Sign In
About ASHM | Careers | Your Cart Shoppint Cart
    Skip Navigation LinksASHM Internet Home > AIAB Board

    AIAB Board


    Co-Chair

    sharon_Lewin copy.jpgPROFESSOR SHARON LEWIN

    Doherty Institute, Melbourne​

    Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; Professor of Medicine, The University of Melbourne; consultant infectious diseases physician, Alfred Hospital, Melbourne, Australia; and an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellow. She is an infectious diseases physician and basic scientist.

    She leads a large multi-disciplinary research team that focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding  a cure for HIV infection. Her other research and clinical interests include immune reconstitution and immune activation post antiretroviral therapy and HIV-hepatitis B virus co-infection.

    She was the local co-chair of the XXth International AIDS Conference (AIDS2014) and is a member of the council of the National Health and Medical Research Council (NHMRC) of Australia, the peak medical research funding body and chairs the NHMRC Health Translation Advisory Committee. In 2014 she was named Melburnian of the Year.​

     

    Co-Chair

    Chris Beyrer Cropped.jpgPROFESSOR CHRIS BEYRER

    Johns Hopkins University, Baltimore

    Chris Beyrer MD, MPH, is Professor of Epidemiology, International Health, and Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health in Baltimore. He is the current President of the International AIDS Society.  Prof. Beyrer serves as Director of JHU’s HIV Training Program in Epidemiology and Prevention Science, and founded and directs the Johns Hopkins Center for Public Health and Human Rights.  He is Co-Principal Investigator of the JHU Center for AIDS Research, CFAR. He currently serves as Co-Chair of the Epidemiology and Natural History Planning Group of the Office of AIDS Research of the U.S. NIH, and serves on the scientific advisory committees on HIV for both UNAIDS and WHO. 

    He has extensive experience in conducting international collaborative research and training programs in HIV/AIDS and other infectious disease epidemiology, in infectious disease prevention research, HIV vaccine preparedness, in health and migration, and in health and human rights. Dr. Beyrer has done research health and human rights concerns in Thailand, Burma, China, India, South Africa, Malawi, Tanzania, Russia, Tajikistan, and Kazakhstan and is the author of over 240 scientific papers.

    Dr. Beyrer received his Medical Degree from the State University of New York Downstate Medical Center in Brooklyn, New York, in 1988, did his medical internship at the University of Wisconsin in Madison in 1988-89, and completed his Residency in Preventive Medicine and Public Health at the Johns Hopkins University in Baltimore in 1992. He also received his MPH from Johns Hopkins in 1991 and completed his Fellowship in Infectious Diseases at the Johns Hopkins Hospital.  He was elected to the Institute of Medicine in 2014 and is a member of the U.S. National Academy of Medicine.  In 2015 he was named the inaugural Desmond M. Tutu Professor of Public Health and Human Rights at Johns Hopkins.

     

    Co-Chair

    PROFESSOR MARK BOYD (ASHM PRESIDENT)​

    Kirby Institute, University of NSW

    Mark Boyd is an Associate Professor of Medicine and a Senior NHMRC Research Fellow working in the Sexual Health Program of The Kirby Institute, UNSW Australia. He is an active HIV/Infectious Diseases physician working in community practice at The Albion Centre and Holdsworth House Medical Practice in inner-city Sydney. Over the past seven years Mark has attracted >$17 million AUD in research funding including a $12.4 million USD grant from the Bill and Melinda Gates Foundation for the conduct of the Encore research program of antiretroviral (ART) dose optimisation. The main study, a randomised, blinded comparison between efavirenz 600mg and 400mg (both given with a tenofovir/emticitabine fixed-dose combination in ART-naïve patients) was published in Lancet in 2014.

    In 2013 he published in Lancet the SECOND-LINE randomised, controlled trial which established the efficacy of WHO-recommended second line ART and showed that a simpler NtRTI-sparing regimen bestows non-inferior efficacy over 96-weeks of follow-up. He has authored more than 80 articles in the peer-reviewed literature and six book chapters.​​

     

     Members

     

    Warwick_Anderson.jpgPROFESSOR WARWICK ANDERSON AM

    Former Head of National Health and Medical Research Council (NHMRC)

    Professor Warwick Anderson AM is the  former Chief Executive Officer (CEO) of NHMRC, Australia's major governmental funding body for health and medical research. Previously, he was Head of School of Biomedical Sciences at Monash University and Deputy Director of the Baker Medical Research Institute, following research fellowships at the University of Sydney and Harvard Medical School.

    ​ Professor Anderson obtained his PhD from the University of Adelaide. His research has focused on renal causes of hypertension, including the roles of renal vascular remodeling, renal innervation and the renin-angiotensin system. He has published over 170 peer review articles.

    Professor Anderson is a Board member of the Global Alliance for Chronic Disease, a member of Heads of International (Biomedical) Research Organizations. He is an Honorary Fellow of the Royal College of Pathologists of Australasia and an International Fellow of the Council for High Blood Pressure of the American Heart Foundation. He serves on the National Science, Technology and Research Committee, and the CRC Committee. He is a member of the International Advisory Committee on Biomedical Science for Singapore. He was made a Member of the Order of Australia in 2005.

    He has been appointed Secretary-General, Human Frontier Science Program effective from July 2015.​

     

    PROFESSOR BERNARD M. BRANSON MD

    Consultant Scientific Affairs;

    Formerly Centre for Disease Control HIV Testing Program

    Since his retirement from CDC in October 2014, Dr. Branson serves as a consultant on the development and commercialization of HIV and HCV diagnostic tests for use in the laboratory and at point-of-care.  He also develops continuing medical education programs on screening and interpretation of diagnostic tests for HIV and HCV infections.

    Dr. Branson spearheaded the effort to develop the updated diagnostic algorithm for HIV infection published by the CDC in June 2014, and served on the committee that developed the recommendations for HCV diagnosis issued in March 2013.  He remains actively involved in developing appropriate diagnostic strategies as new tests and techniques become available.​


    PROFESSOR DAVID COOPER

    Head Kirby Institute, University of NSW

     

    IACSamsuridjal Djauzi.jpgPROFESSOR SAMSURIDJAL DJAUZI

    University of Indonesia; Indonesian Association of Physicians in AIDS Care​

    Graduate from Faculty of medicine University of Indonesia (1969)

    PhD In Medicine University of Indonesia (1989)

    Specialist in Internal Medicine (1976)

    Consultant in Allergy Immunology (1986)

    Lecturer at Faculty of medicine University of Indonesia since 1981

    Main activities : HIV and Hepatitis Care


    dorephoto_final.jpgPROFESSOR GREG DORE

    Viral Hepatitis Program, Kirby Institute

    Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Australia, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia.  He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years. He has developed extensive national and international collaborations, and is internationally recognized in the areas of natural history of acute and chronic HCV infection, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs.

    He holds large-scale ongoing public sector research funding from U.S. National Institutes for Health, Canadian Institutes for Health Research, and Australian National Health and Medical Research Council (NHMRC). 

    Professor Dore has been President of the Australasian Society for HIV Medicine (ASHM), a member of NHMRC Council, and currently is a NHMRC Practitioner Fellow.

     

    IACalecekeroma.jpgDR ALEC EKEROMA

    Former President

    Pacific Society for Reproductive Health​

    Alec is the President of the Pacific Society for Reproductive Health 2011-2015. He is a Senior Lecturer and Head of the Pacific Women's Health Research Unit at the University of Auckland. He is a senior consultant in O&G at Middlemore Hospital in Auckland.  He is completing a PhD into building research capacity in the Pacific Islands.

    Alec was the Chair of the NZ Committee of RANZCOG and has been on the Council of both RANZCOG and AOFOG. He was the President of the Pacific Medical Association and has been the founder and on governance boards of some Pacific primary health care organisations in Auckland NZ. He has also been on various national health committees of the Ministry of Health. 

    His research interests are postnatal depression, stillbirths, gestational diabetes, sexually transmitted infections, Vitamin D in pregnancy and building research capacity. He has published 42 articles in peer-reviewed journals. He has research collaborations and networks with teams across NZ Universities and across the Pacific. Alec led a team that wrote the medical curriculum for the Faculty of Medicine National University of Samoa. He is about to complete a PhD in building research capacity in the Pacific. As part of his capacity building work, Alec has founded and is the Chief-in-Editor of the Pacific Journal of Reproductive Health and is cultivating a group of that will form a Reproductive Health Research Network in the Pacific. He recently co-edited the Pacific Emergency Maternal and Neonatal Training Manual for nurses and doctors in the Pacific.​

     

    IACdavidlewis.jpgPROFESSOR DAVID LEWIS

    University of Sydney,

    Director Western Sydney Sexual Health Centre,

    ​ David Lewis is Director of the Western Sydney Sexual Health Centre and Professor at the University of Sydney. He is also the Discipline Leader for STI/HIV within the Marie Bashir Institute for Infectious Diseases and Biosecurity.  Until mid-2014, he held the position of Head of the Centre for HIV and STIs at the National Institute for Communicable Diseases in South Africa. David’s research interests focus on gonorrhoea, genital ulcer disease, STI care in resource-poor settings, outreach STI services and men’s sexual health. 

    He serves at the elected President of the International Union against STIs (IUSTI).  He is a Deputy Editor for Sexually Transmitted Infections and also a Joint Editor for Sexual Health. David frequently assists the World Health Organization (WHO) as a Technical Advisor on matters related to STI treatment guidelines, the proposed 2016-2025 STI strategy, point-of-care diagnostic tests and the WHO’s Gonococcal Antimicrobial Susceptibility Programme (GASP). ​

     

    IACannmareeokeeffejpg.jpgANNMAREE O'KEEFFE
    ​Lowey Institute (former Australia HIV Ambassador)​​

    Annmaree O'Keeffe has extensive experience in international relations and development and has worked in Asia, Africa and the Pacific in various roles including as Australia's ambassador to Nepal, head of Australia's international aid program in Papua New Guinea, Australia's first ambassador for HIV/AIDS and Deputy Director General of Australia's official development assistance program. 

    Now a non-resident fellow at the Lowy Institute for International Policy and research associate at the ANU's Development Policy Centre, she works extensively on health development issues, particularly HIV/AIDS, and was a member of AIDS 2014 coordinating committee as well as the local co-chair for the conference's sub-committee on leadership and accountability. 

    Annmaree was a founding director of the Asia Pacific Business Coalition for AIDS, is a member of the advisory council for the Pacific Friends of the Global Fund for AIDS, TB and Malaria, and was recently appointed to ASHM's International Advisory Board.  She is also the chair of Australia's national commission for UNESCO. 


    BEN COWIE (3).jpgASSOCIATE PROFESSOR BEN COWIE
    Victorian Infectious Diseases Reference Laboratory and Head of the World Health Organization Collaborating Centre on Viral Hepatitis

     Ben is an Infectious Diseases Physician and Epidemiologist from Melbourne. He is Director of the newly-designated WHO Collaborating Centre for Viral Hepatitis at the Doherty Institute, and is acting Head of the Epidemiology Unit at the Victorian Infectious Diseases Reference Laboratory (VIDRL). His clinical appointment is with the Victorian Infectious Diseases Service at the Royal Melbourne Hospital, with a focus on providing care for people living with viral hepatitis. He is an Honorary Principal Fellow in the Department of Medicine at the University of Melbourne.

     Ben’s main area of research interest is the epidemiology and control of communicable diseases, particularly viral hepatitis. He serves on a range of state, national and international committees related to communicable disease control and the development of healthy public policy in relation to viral hepatitis.


    Margaret Hellard1.jpgPROFESSOR MARGARET HELLARD
    Head of the Centre for Population Health, Burnet Institute Melbourne,

    Head of Hepatitis Services in the Infectious Diseases Unit, The Alfred Hospital,
    Adjunct Professor of Infectious Diseases Epidemiology, Monash University.

    Margaret’s principal research interests are in preventing the transmission and improving the management of blood borne viruses and sexually transmitted infections. She has considerable experience in undertaking multidisciplinary community based research involving people who inject drugs (PWID), men who have sex with men and other vulnerable populations.

    Margaret is a Principal Investigator of the two world first studies, the TAP Study which is examining the efficacy hepatitis C treatment as prevention in PWID, using a community based social network approach, and the PRIME Study, a randomised controlled study exploring hepatitis C models of care in the community. As well, she is involved in a number of studies examining how to increase the frequency of HIV testing and linking HIV positive people to care.

    Margaret has been instrumental in the development of innovative sentinel surveillance systems for BBVs and STIs both within Victoria and nationally.  She also has considerable experience in undertaking research that used new technologies (such as SMS, Facebook) for health promotion and prevention interventions.

    Margaret is a member of numerous advisory committees and working groups on viral hepatitis and HIV within Australia and globally; she recently chaired the WHO Guideline Development Group for Hepatitis Testing.  She has over 250 peer reviewed publications and received over $30 million in competitive grants and tenders


    AK Photo 0514BW2.jpgPROFESSOR ADEEBA KAMARULZAMAN
    University of Malaya, Kuala Lumpur

    Professor Adeeba Kamarulzaman graduated from Monash University in 1987 and trained in internal medicine and infectious diseases at the Monash Medical Centre and Fairfield Infectious Diseases Hospital, Melbourne, Australia. She is presently the Dean of the Faculty of Medicine, University of Malaya and Adjunct Associate Professor at Yale University, USA.

    Professor Adeeba returned to Malaysia in 1997 and established the Infectious Diseases Unit at the University Malaya Medical Centre. In 2007 she established the Centre of Excellence for Research in AIDS (CERiA) at the University of Malaya to develop and enhance HIV/AIDS research activities in Malaysia. She is currently Chairman of the Malaysian AIDS Foundation. At the international level, Professor Adeeba is presently the Co-Chair of the WHO Strategic and Technical Advisory Committee on HIV, an Executive Committee Member of the International Society of Infectious Diseases and a Governing Council Member of the International AIDS Society and was recently appointed as a member of The Lancet Commission on Drugs and Health. She has played a key role in the establishment and ongoing activities and collaborations of a regional HIV research network initiative; TREAT Asia. 


     Nguyen Van KinhBW.jpgAssociate Professor Dr NGUYEN VAN KINH
    Vietnamese Clinical HIV/AIDS Society

    Dr Nguyen Van Kinh is  an Infectious Diseases physician. He graduated from Hanoi Medical University as a medical doctor in 1982 and finished Internal Medicine residency at Hanoi Medical University in 1985. He completed one year fellowship on Infectious Diseases in Pasteur Paris Institute, France in 1991.

     He has had many experiences on Infectious Diseases, especially in HIV/AIDS and has been PI in various research such as HIV/AIDS, viral hepatitis, dengue hemorragic fever, influenza, hand food and mouth diseases.  His articles have been published in the National and International journal (32 International and 57 National articles)

     He has been Director of National Hospital for Tropical Diseases (NHTD) and a chief of the Department of Infectious Diseases, Hanoi Medical University since 2008. He is the chairman of Vietnamese Society of Infectious Disease, chairman of Vietnam Clinical HIV/AIDS society and also the chairman of Scientific Committee-Ethic Committee of NHTD.  


     Katherine Lepani.jpgDr Katherine Lepani
    COLLEGE of ASIA and the PACIFIC, ANU

    Katherine Lepani is a cultural anthropologist with a specialist focus on public health. She is currently a senior research associate in the School of Culture, History and Language, College of Asia and the Pacific, at The Australian National University, where she has taught graduate coursework for the Master of Culture, Health, and Medicine and Master of Public Health programs, and has recently co-developed and convened a new course on Gender and Sexuality in the Pacific. She has been involved in HIV policy and program work in Papua New Guinea and the Pacific Islands region since the mid-1990s, including coordinating the development of PNG's first national multi-sectoral strategy for HIV in 1997, and the PNG National HIV Prevention Strategy 2010-2015. Her book Islands of Love, Islands of Risk: Culture and HIV in the Trobriands (Vanderbilt University Press, 2012), based on her PhD thesis, is the first full-length ethnography that examines the interface between global and local understandings of gender, sexuality, and HIV in a Melanesian cultural context. 


    SALocarnini.jpgSteve Locarnini
    The Coalition for the Eradication of Viral Hepatitis in Asia Pacific (CEVHAP) 

    Professor Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path) is from the Victorian Infectious Diseases Reference Laboratory (VIDRL, originally Fairfield Hospital Laboratory) where he has worked since 1989. He was Director of Laboratory Services from 1990-1998 and then assumed the position of Head, Research & Molecular Development of VIDRL. He is also Director of World Health Organisation (WHO) Regional Reference Laboratory for Hepatitis B. His current major research interests include viral hepatitis, hepatitis vaccines, and antiviral chemotherapy with an emphasis on the basic virology of the various agents of hepatitis, the molecular pathogenesis of hepatitis, as well as prevention and public health control measures. The treatment of hepatitis B and C infections with antiviral agents represents a major focus. He is also interested in intellectual property issues when applied to clinical virology.

    Professor Locarnini is the recipient of numerous awards including the Malaysian Liver Foundation Medal for work on Viral Hepatitis, the Bristol Myers Squibb Freedom to Discover Award and is the 2011 recipient of the European Association for the Study of the Liver (EASL) award for Scientific Recognition. He is author of over 200 peer-reviewed articles, 15 invited editorials and over 70 book chapters and reviews and every year for the past 5 years, has delivered a number of invited and plenary lectures at major international conferences.

    Professor Locarnini has his academic appointment at Melbourne University.  He is on a number of Scientific Advisory Boards of a number of pharmaceutical and biotechnology companies. He is the Hepatitis Virus Editor for Antiviral Therapy and on the Editorial Board of Antiviral Research, Antimicrobial Agents & Chemotherapy, Hepatology International, Journal of Hepatology, and Journal of Clinical and Experimental Hepatology. His has recently co-founded the NGO, Coalition to Eradicate Viral Hepatitis in Asia-Pacific (CEVHAP).


     KIATBW.jpgDr KIAT RUXRUNGTHUN
    Professor of Medicine, Department of Medicine Chulalongkorn University
    Scientific chair, Chula Vaccine Research Center,
    Chulalongkorn University; and

    Deputy Director, HIV-NAT, Thai Red Cross AIDS Research Center

    He provides teaching and patient care at the King Chulalongkorn Memorial Hospital, and is mentoring junior researchers on vaccine, immunology research and also on clinical trials. He has published more than 260 peer review papers on HIV, immunology and allergy.

    He is a faculty member of the faculty 1000 of Medicine, an editorial board member of Asia Pacific J of Allergy and Immunology, ImmunoTargets and Therapy, Asian Biomedicine, and the  Scientific Report. He is also a reviewer for more than 9 journals. 

    Specialty & Research Field of Interest
    His research areas of interest include HIV treatment strategies, HIV T cell immunology, vaccine development (including dengue, HIV and house dust mite vaccine); and strategies to improve DNA vaccine immunogenicity. He has currently expanded his research to humanized mouse model and non-human primate studies. 

     
    Dr ANNETTE SOHN
    Director, TREAT Asia
    Vice President, amfAR – The American Foundation for AIDS Research (anfaAR)

    Dr. Sohn is the Director of TREAT Asia and a Vice President of amfAR – The Foundation for AIDS Research.  She is based in Bangkok, Thailand, where she oversees an HIV research program in collaboration with 60 adult and pediatric clinical sites in 13 countries across the region that are part of the US National Institutes of Health’s International Epidemiologic Databases to Evaluate AIDS (IeDEA) global cohort consortium.  Her research interests are in adult and pediatric HIV cohort analyses, pediatric and adolescent HIV and co-infection treatment outcomes, and antiretroviral drug resistance.  She trained in Pediatrics and Pediatric Infectious Diseases at the University of California, San Francisco.  

     
    Joerg_final.jpgJOERG BOECKELER
    Intercontinental Hotel Group Sydney

    Jörg T. Böckeler joined InterContinental Sydney as General Manager in 2013, concurrently being appointed as Area General Manager of Mulpha Hotels Australia – owner of InterContinental Sydney and InterContinental Sanctuary Cove Resort.

     An accomplished international luxury hotelier, German-born Jörg has more than 30 years’ experience in hotels and hospitality, holding executive roles at flagship hotels across Europe, Africa and Australia.

     Jörg holds a Bachelor of Science Honours degree from Oxford Brooks University, a Master of Business Administration (MBA Executive) from Imadec University Vienna, and in 2011 was awarded the Knight’s Cross of the Order of Merit of the Federal Republic of Germany.

     For the past twenty-five years Jörg has been active in the philanthropic arena with a particular focus on fund raising for HIV research and HIV education.     

    Jörg has been appointed Director of the Board, for the German-Australian Chamber of Industry and Commerce, he is also a Member of the Board for the TAA, NSW. In addition, Jörg is a Governor of the American Chamber of Commerce, a Counsellor of the EABC and is the President of La Chaîne des Rôtisseurs, Chapter NSW.

     
    Levinia 2015_2.jpgADJUNCT ASSOCIATE PROFESSOR LEVINIA CROOKS
    CEO, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)

    Public Health and HUman Biosciences, La Trobe University

    Levinia is Chief Executive Officer of Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine and Co-chair of the HIV Testing Policy Expert Reference Committee. She is an Adjunct Associate Professor in Public Health and Human Biosciences at La Trobe University. She has worked in the HIV sector since 1986, initially as a social researcher, looking at the development of support services for people living with HIV. She has a keen interest in the translation of research into policy and practice. She has qualifications in Education and Management and been a leader in the transfer of skilled learned in the HIV setting into responses to viral hepatitis and sexual health. She has been awarded the Order of Australia for her work in the sector.

     


    Please enter a valid E-mail.
    This must match your colleagues E-mail.
    Please enter your name.
    Please enter a valid email.
    This must match your email.